Demographic and Some Underlying Factors in Patients with Sepsis in Alzahra Hospital, Isfahan, Iran

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, Student Research Committee, School of Medicine AND Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Sepsis is one the ten main causes of death in hospitalized patients. Due to high prevalence of sepsis and other related syndromes, adverse effects of this syndrome and high rate of death due to sepsis in patients admitted to Alzahra Hospital, Isfahan, Iran, we decided to evaluate associated factors, demographic data, and underlying diseases which may develop sepsis in patients referred to this hospital.Methods: This was a cross-sectional study on 229 patients with criteria of sepsis referred to Alzahra hospital during 2011-15. Demographic characteristics were recorded. Patients were evaluated base on the immunity status. Patients' blood, urine, and wound specimens underwent culture. P < 0.05 was considered as significant.Findings: The mean age of patients was 69.17 ± 17.84 years. 52% of patients were male and 48% were female. The mean age and duration of hospitalization were 71.82 ± 17.27 years and 9.93 ± 9.55 days among dead and 85.43 ± 18.06 years and 13.40 ± 9.70 days among improved patients (P = 0.007 and P = 0.008, respectively). Immunodeficiency did not play significant role in prognosis of sepsis (P = 0.795) while the etiology of pneumonia (P = 0.030) and being bedridden (P < 0.001) had significant role in prognosis of sepsis.Conclusion: According to this study, age, being bedridden, underlying disease, and also immunodeficiency can be considered as independent factors for sepsis prognosis.

Keywords

References

  1. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011; 6: 19-48.
  2. Juncal VR, Britto Neto LA, Camelier AA, Messeder OH, Farias AM. Clinical impact of sepsis at admission to the ICU of a private hospital in Salvador, Brazil. J Bras Pneumol 2011; 37(1): 85-92.
  3. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12(6): R158.
  4. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 2004; 8(4): R251-R260.
  5. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164(3): 396-402.
  6. BalcI C, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7(1): 85-90.
  7. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29(4): 530-8.
  8. Wilhelms SB, Huss FR, Granath G, Sjoberg F. Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: difficulties with methods and interpretation of results. Crit Care Med 2010; 38(6): 1442-9.
  9. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30(4): 589-96.
  10. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30(4): 580-8.
  11. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31(9): 2332-8.
  12. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311(13): 1308-16.
  13. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-54.
  14. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274(8): 639-44.
  15. Dhainaut JF, Vincent JL, Richard C, Lejeune P, Martin C, Fierobe L, et al. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit Care Med 1995; 23(9): 1461-9.
  16. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278(3): 234-40.
  17. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006; 129(4): 968-78.
  18. Labelle A, Juang P, Reichley R, Micek S, Hoffmann J, Hoban A, et al. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment. Crit Care Med 2012; 40(7): 2016-21.
  19. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365(9453): 63-78.
  20. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23(10): 1638-52.
  21. De La Rica AS, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries. Ann Transl Med 2016; 4(17): 325.
  22. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34(1): 15-21.
  23. Giri S, Kindo AJ. A review of Candida species causing blood stream infection. Indian J Med Microbiol 2012; 30(3): 270-8.
  24. Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35(5): 1284-9.
  25. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34(2): 344-53.
  26. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302(21): 2323-9.
  27. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274(12): 968-74.
  28. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006; 34(10): 2576-82.
Journal of Isfahan Medical School
Volume 35, Issue 418 - Serial Number 418
January and February 2017
Pages 42-49

Files

History

  • Receive Date: 08 November 2016
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics